Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Pediatric Lymphomas

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    COGANHL04B1

    09/14/2006

    Rare and Cutaneous Non-Hodgkin Lymphoma Registry

    Treatment

    VICCPED1537

    04/28/2016

    T2014-001 A Phase I Trial of Temsirolimus (CC-779, Pfizer, Inc.) in Combination with Etoposide and Cyclophosphamide in Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

    Treatment

    COGAALL1231

    05/13/2015

    A Phase III Randomized Trial Investigating Bortezomib NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)


    Print this page for your doctor